• EZ Cap Cy5 Firefly Luciferase mRNA Workflow

  2026-08-13

  Track mRNA uptake and functional protein expression in the same experiment with a Cy5 fluorescence signal and Firefly luciferase readout. This practical workflow shows how to optimize delivery, interpret discordant signals, and translate the dual-reporter design into microglia, vaccine, gene therapy, and imaging studies.

• AI-10-49 in inv(16) AML Research

  2026-08-12

  AI-10-49 enables mechanism-driven acute myeloid leukemia research by disrupting the CBFβ-SMMHC–RUNX1 interaction rather than relying only on nonspecific cytotoxicity. This guide connects dose-response, chromatin immunoprecipitation assay, transcriptional, and in vivo workflows to practical optimization and troubleshooting.

• Prostaglandin E2: Applied Workflows and Troubleshooting

  2026-08-12

  Use Prostaglandin E2 as a defined EP-receptor stimulus for inflammation research, barrier biology, immune regulation, and reproductive medicine applications. This workflow combines receptor-aware dosing with stability controls and a careful interpretation of new vaccine-immunity findings involving arachidonic acid and PGI2.

• From Natural Products to Antiparasitic Mechanism

  2026-08-11

  Mechanism-driven screening can convert natural-product diversity into actionable antiparasitic hypotheses. By pairing metabolic vulnerability, orthogonal assays, and translational controls, researchers can use DiscoveryProbe™ Natural Product Library Plus to move beyond hit discovery toward defensible lead selection.

• Phosphatase Inhibitor Cocktail 3 in Ferroptosis Assays

  2026-08-10

  Phosphatase Inhibitor Cocktail 3 helps preserve phosphorylation during lysate preparation, enabling more reliable analysis of ferroptosis-linked signaling. This article explains how to use it as a preanalytical control when studying mPTP, mtDNA release, and cGAS–STING biology.

• H5N1 mRNA Vaccine Protection in Lactating Dairy Cows

  2026-08-09

  A hemagglutinin-encoding mRNA–lipid nanoparticle vaccine protected lactating dairy cows from high-dose H5N1 challenge without detectable effects on health or milk production. The study is notable for demonstrating durable protection in a production-animal model, including protection in some cows despite very low serum antibody levels weeks after vaccination.

• PRMT5, Splicing, and Metabolism in MYCN Neuroblastoma

  2026-08-08

  The reference study shows that MYCN-amplified neuroblastoma depends on PRMT5-regulated RNA splicing, epitranscriptomic control, and glutamine metabolism. Its integrated genetic, transcriptomic, isotope-tracing, and in vivo analyses identify a mechanistic connection between spliceosomal disruption and reduced GLS protein abundance, offering a framework for studying metabolic liabilities in aggressive neuroblastoma.

• Recombinant Human Oncostatin M: Applied Workflows

  2026-08-07

  Use rh-Oncostatin M as a controlled perturbation for proliferation, cytokine-release, and stress-response assays rather than as a one-size-fits-all growth factor. This workflow combines product-specific handling guidance with lipid-droplet and autophagy readouts inspired by recent small-cell lung cancer radioresistance research.

• Carbenoxolone disodium: Technical Protocols for 11β-HSD Inhi

  2026-08-07

  Carbenoxolone disodium provides a reliable approach to inhibit 11β-hydroxysteroid dehydrogenase activity and gap junction communication in cell and tissue-based research. It is best suited for mechanistic studies of glucocorticoid signaling and should not be used for in vivo efficacy studies or experiments requiring strict off-target specificity.

• NHS-Biotin: Optimizing Biotinylation for Advanced Protein La

  2026-08-06

  NHS-Biotin, an amine-reactive biotinylation reagent, enables efficient and site-specific labeling of antibodies and proteins for advanced detection and purification workflows. Leveraging membrane permeability and stable amide bond formation, it empowers researchers to address complex challenges in multimeric protein engineering and intracellular protein analysis.

• E-64: L-trans-epoxysuccinyl Peptide for Precision Protease A

  2026-08-06

  E-64, a potent L-trans-epoxysuccinyl peptide, empowers researchers to irreversibly inhibit cysteine proteases with nanomolar precision in cell-based and animal models. This guide translates recent breakthroughs and practical workflow insights into actionable steps for maximizing E-64's impact in mechanistic, cancer, and renal research.

• Isoprinosine (Inosine Pranobex): Advanced Insights into Immu

  2026-08-05

  Explore the mechanistic depth and translational applications of Isoprinosine (inosine pranobex) as an immunomodulatory and antiviral agent. This article uniquely connects membrane fusion biology and immunotherapy for viral infections, providing actionable guidance for cutting-edge research.

• Molidustat (BAY85-3934): Applied HIF Stabilization in CKD An

  2026-08-05

  Molidustat (BAY85-3934) offers a groundbreaking avenue for modeling erythropoietin stimulation and hypoxia-inducible factor stabilization in chronic kidney disease anemia research. This guide details experimental workflows, troubleshooting tactics, and the translational edge provided by Molidustat, drawing on the latest mechanistic and publication-backed insights.

• CD109 Drives Stemness and Chemoresistance in Colorectal Canc

  2026-08-04

  This study identifies CD109 as a central regulator of stemness and chemoresistance in advanced colorectal cancer (CRC) through a previously uncharacterized LRRC8A/AKAP12/PKCα-STAT3-WNT signaling axis. Genetic or pharmacological disruption of this pathway reduces cancer stemness, restores drug sensitivity, and impairs metastatic capacity, suggesting new targets for overcoming drug resistance in CRC.

• Cy3 Rabbit Anti-Goat IgG (H+L) Antibody: Technical Workflow

  2026-08-04

  The Cy3 Rabbit Anti-Goat IgG (H+L) Antibody enables sensitive fluorescence-based detection of goat IgG in assays such as ICC/IF, IHC, flow cytometry, and ELISA. It is intended only for workflows involving goat primary antibodies and is not suitable for non-goat primaries or non-immunoglobulin targets.

449 records 8/30 page Previous Next First page 上5页 678910 下5页 Last page